Revelation Biosciences Inc

Penny Stocks Biotech Stocks Healthcare Stocks

$1.05

-0.06 (-5.50%)

As of Aug 14, 10:29 PM ET ·

Analyst Consensus

Strong Buy

Analysts

Moderate

Coverage

Buy 6 86%

Hold 1 14%

Sell 0 0%

Price Target

Analyst Price Target +873.3% upside

Low Target $7.91

Average Target $10.21

High Target $15.75

Current Price $1.05

Current
$1.05

Target
$10.21

$7.91 $10.21 avg $15.75

Scenario Analysis

Bear Case

$7.91

654.1%

Low target

Base Case

$10.21

+873.3%

Avg target

Bull Case

$15.75

+1,401.4%

High target

Risk/Reward

2.1x

Favorable

Price in Context

52-Week High

$11.72

-91.0% from high

52-Week Low

$0.88

+19.9% from low

Target vs 52W High

$10.21

-12.9% vs high

Peer Consensus — Biotechnology

Stock	Consensus	Analysts	Buy %	Target	Upside
ABBV Abbvie Inc	Strong Buy	38	82%	$257.58	+3.3%
AMGN Amgen Inc	Hold	43	49%	$190.87	-54.0%
GILD Gilead Sciences Inc	Strong Buy	37	81%	$362.68	+162.1%
VRTX Vertex Pharmaceuticals Inc	Strong Buy	37	81%	$438.34	-13.3%
REGN Regeneron Pharmaceuticals	Buy	37	70%	$76.80	-90.4%
NTRA Natera Inc	Strong Buy	30	87%	$142.91	-53.9%
RVMD Revolution Medicines Inc	Strong Buy	28	93%	$114.11	-44.0%
BIIB Biogen Inc	Buy	43	67%	$91.45	-56.4%